Skip to main content

Current Problems of Iron Overload

  • Conference paper
Strategies in Clinical Hematology

Abstract

Normally the body store of iron which is surplus to immediate requirements is regulated somewhere between 0 and 2000 mg, depending on the balance between the amounts of available dietary iron ingested and the individual’s need for iron to replace losses and to provide for growth. In order for iron stores to be increased above 2000 mg, additional iron must gain access to the body. There are two ways in which this can occur — by increased iron absorption or by parenteral iron administration. Absorption may be increased as a result of the ingestion of large amounts of iron over long periods, although it appears difficult to overcome the ability of the intestinal mucosa to regulate the quantity assimilated. At present the most convincing example of oral iron overload in the face of a normal regulatory absorptive mechanism is provided by the black populations of southern Africa, who ingest large amounts of iron in fermented alcoholic beverages [11]. Oral iron overload may also occur when the iron content of the diet is not excessive. In the metabolic disorder idiopathic haemochromatosis there is a failure of the homeostatic mechanism controlling absorption and a state of positive iron balance continues indefinitely so that there is a steady build-up in the iron content of the body [6]. A similar situation occurs in certain chronic refractory anaemias, notably thalassaemia major, and in certain patients with liver disease [16]. Parenteral iron overload is nearly always due to treatment of refractory nonhaemorrhagic anaemias with multiple blood transfusions. There are about 225 mg iron in each unit of blood, and since the body’s ability to excrete unwanted iron is limited, its iron content is increased by this amount.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

References

  1. Barry, M., Flynn, D. M., Letsky, E. A., Risdon, R. A.: Long-term chelation therapy in thalassae-mia major: effect on liver iron concentration, liver histology and clinical progress. Br. Med. J. 1974 II, 16–20

    Article  Google Scholar 

  2. Bezwoda, W. R., Bothwell, T. H., Van der Walt, L. A., Kronheim, S., Pimstone, B. L.: An investigation into gonadal dysfunction in patients with idiopathic hemochromatosis. Clin. Endocrinol. 6, 377–385 (1977)

    Article  CAS  Google Scholar 

  3. Bomford, A., Eddleston, A. L. W. F., Kennedy, L. A., Batchelor, J. R., Williams, R.: Histoeompat-ability antigens as markers of abnormal iron metabolism in patients with idiopathic haemochro-matosis and their relatives. Lancet 1977 I, 327–329

    Article  Google Scholar 

  4. Bothwell, T. H., Charlton, R. W.: Dietary iron overload. In: Iron metabolism and its disorders. Kief, H. (ed.), pp. 221–229. Amsterdam: Excerpta Medica 1975

    Google Scholar 

  5. Bothwell, T. H., Charlton, R. W.: Hemochromatosis. In: Diseases of the liver. Schiff, L. (ed.), pp. 971–999. Philadelphia, Toronto: Lippincott 1975

    Google Scholar 

  6. Bothwell, T. H., Finch, C. A.: Iron metabolism. Boston: Little & Brown 1962

    Google Scholar 

  7. Bothwell, T. H., Derman, D., Bezwoda, W. R., Torrance, J. D., Charlton, R. W.: Can iron fortification of flour cause damage to genetic susceptibles (idiopathic haemochromatosis and β-thalassaemia). Hum. Genet. [Suppl.] 1, 131–137 (1978)

    CAS  Google Scholar 

  8. Brink, B., Disler, P., Lynch, S., Jacobs, P., Charlton, R., Bothwell, T.: Patterns of iron storage in dietary iron overload and idiopathic hemochromatosis. J. Lab. Clin. Med. 88, 725–731 (1977)

    Google Scholar 

  9. Charlton, R. W., Bothwell, T. H.: Hemochromatosis: dietary and genetic aspects. In: Progress in hematology. Brown, E. B., Moore, C. V. (eds.), Vol. 5, pp. 298–323. New York: Grune & Stratton 1966

    Google Scholar 

  10. Charlton, R. W., Bothwell, T. H.: Iron, ascorbic acid and thalassemia. In: Iron metabolism in thalassemia. Bergsma, D., Cerami, A., Peterson, C. M., Graziano, J. H. (eds.), pp. 63–80. New York: Liss 1976

    Google Scholar 

  11. Charlton, R. W., Bothwell, T. H., Seftel, H. C.: Dietary iron overload. In: Clinics in haematology. Callender, S. T. (ed.), Vol. 2, pp. 383–404. London: Saunders 1973

    Google Scholar 

  12. Cooper, B., Bunn, H. F., Propper, R. D., Nathan, D. G., Rosenthal, D. S., Maloney, W. C.: Treatment of iron overload in adults with continuous parenteral desferrioxamine. Am. J. Med. 63, 958–966 (1977)

    Article  PubMed  CAS  Google Scholar 

  13. Fillet, G., Marsaglia, G.: Idiopathic hemochromatosis (IH). Abnormality in RBC transport of iron by the reticuloendothelial system (RES). Blood 46, 1007 (1975)

    Google Scholar 

  14. Finch, C. A., Deubelbeiss, K., Cook, J. D., Eschbach, J. W., Harker, L. A., Funk, D. D., Marsaglia, G., Hillman, R. S., Slichter, S., Adamson, J. W., Ganzoni, A., Giblett, E. R.: Ferrokinetics in man. Medicine 49, 17–53 (1970)

    Article  PubMed  CAS  Google Scholar 

  15. Goldberg, L., Smith, J. P., Martin, L. E.: The effects of intensive and prolonged administration of iron parenterally in animals. Br. J. Exp. Pathol. 38, 297–311 (1957)

    Google Scholar 

  16. Grace, N. D., Powell, L. W.: Iron storage disorders in the liver. Gastroenterology 64, 1257–1283 (1974)

    Google Scholar 

  17. Grady, R. W.: The development of new drugs for use in iron chelation therapy. In: Iron metabolism in thalassemia. Bergsma, D., Derami, A., Peterson, C. M., Graziano, J. H. (eds.), pp. 161–175. New York: Liss 1976

    Google Scholar 

  18. Heinrich, H. C., Gabbe, E. E., Oppitz, K. H., Whang, D. H., Götze, C. B., Schäfer, K. H., Schröter, W., Pfau, A. A.: Absorption of inorganic and food iron in children with heterozygous and homozygous beta-thalassemia. Z. Kinderheilkd. 115, 1–22 (1973)

    Article  PubMed  CAS  Google Scholar 

  19. Henke, J., Ungar, W.: HLA-antigens in idiopathic haemochromatosis. Preliminary report. Z. Immunitätsforsch. Immunobiol. 154, 41–43 (1978)

    CAS  Google Scholar 

  20. Henry, W. L., Nienhuis, A. W.: Possible adverse effects of ascorbic acid on cardiac function in patients with myocardial iron overload. Blood 5, 993 (1977)

    Google Scholar 

  21. Hershko, C., Graham, G., Bates, G. W., Rachmilewitz, E. A.: Nonspecific serum iron in thalassemia-abnormal serum iron fraction of potential toxicity. Br. J. Haematol. 40, 255–263 (1978)

    Article  PubMed  CAS  Google Scholar 

  22. Hunt, J., Richards, R. J., Harwood, R., Jacobs, A.: The effect of desferrioxamine on fibroblasts and collagen formation in cell cultures. Br. J. Haematol. 41, 69–76 (1979)

    Article  PubMed  CAS  Google Scholar 

  23. Hussain, M. A. M., Flynn, D. M., Green, N., Hoffbrand, A. V.: Effect of dose, time, and ascorbate on iron excretion after subcutaneous desferrioxamine. Lancet 1977 I, 977–979

    Article  Google Scholar 

  24. Hyman, C. B., Landing, B., Alfin-Slater, R., Kozak, L., Weitzman, J., Ortega, J. A.: dl-Alpha-tocopherol, iron, and lipofuscin in thalassemia. Ann. N.Y. Acad. Sci. 232, 211–220 (1974)

    Article  PubMed  CAS  Google Scholar 

  25. Lipschitz, D. A., Bothwell, T. H., Seftel, H. C., Wapnick, A. A., Charlton, R. W.: The role of ascorbic acid in the metabolism of storage iron. Br. J. Haematol. 20, 155–163 (1971)

    Article  PubMed  CAS  Google Scholar 

  26. MacDonald, R. A.: Hemochromatosis and hemosiderosis. Springfield, Ill.: Thomas 1964

    Google Scholar 

  27. MacPhail, A. P., Simon, M. O., Torrance, J. D., Charlton, R. W., Bothwell, T. H., Isaacson, C.: Changing patterns of dietary iron overload in black South Africans. Am. J. Clin. Nutr. (in press)

    Google Scholar 

  28. Modell, B.: Total management of thalassaemia major. Arch. Dis. Child. 52, 489–500 (1977)

    Article  PubMed  CAS  Google Scholar 

  29. Peters, T. J., Seymour, C. A.: Acid hydrolase activities and lysosomal integrity in liver biopsies from patients with iron overload. Clin. Sci. Molec. Med. 50, 15–1% (1976)

    PubMed  CAS  Google Scholar 

  30. Pippard, M. J., Callender, S. T., Weatherall, D. J.: Intensive iron-chelation therapy with desferrioxamine in iron-loading anaemias. Clin. Sci. Mol. Med. 54, 99–106 (1978)

    PubMed  CAS  Google Scholar 

  31. Rowe, J. W., Wands, J. R., Mezey, E., Waterbury, L. A., Wright, J. R., Tobin, J., Andres, R.: Familial hemochromatosis: characteristics of the precirrhotic stage in a large kindred. Medicine 56, 197–211 (1977)

    Article  PubMed  CAS  Google Scholar 

  32. Seymour, C. A., Peters, T. J.: Organelle pathology in primary and secondary haemochromatosis with special reference to lysosomal changes. Br. J. Haematol. 40, 239–253 (1978)

    Article  PubMed  CAS  Google Scholar 

  33. Simon, M., Bourel, M.: Hérédité de l’hémochromatose idiopathique: démonstration de la transmission récessive et mise en évidence du gène responsable porté par le chromosome 6. Gastroenterol. Clin. Biol. 2, 573–577 (1978)

    PubMed  CAS  Google Scholar 

  34. Simon, M., Bourel, M., Fauchet, R., Genetet, B.: Association of HLA-A3 and HLA-B14 antigens with idiopathic haemochromatosis. Gut 17, 332–334 (1976)

    Article  PubMed  CAS  Google Scholar 

  35. Trump, B. F., Valigorsky, J. M., Arstila, A. U., Mergner, W. J., Kinney, T. D.: The relationship of intracellular pathways of iron metabolism to cellular iron overload and the iron storage diseases. Am. J. Pathol. 72, 295–324 (1973)

    PubMed  CAS  Google Scholar 

  36. Wapnick, A. A., Lynch, S. R., Krawitz, P., Seftel, H. C., Charlton, R. W., Bothwell, T. H.: Effects of iron overload on ascorbic acid metabolism. Br. Med. J. 1968 III, 704–707

    Article  Google Scholar 

  37. Weatherall, D. J., Pippard, M. J., Callender, S. T.: Iron loading and thalassemia — experimental successes and practical realities. N. Engl. J. Med. 297, 445–446 (1977)

    Article  PubMed  CAS  Google Scholar 

  38. Wheby, M. S., Umpierre, G.: Effect of transferrin saturation on iron absorption in man. N. Engl. J. Med. 271, 1391–1395 (1964)

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1979 Springer-Verlag Berlin · Heidelberg

About this paper

Cite this paper

Bothwell, T.H., Charlton, R.W. (1979). Current Problems of Iron Overload. In: Gross, R., Hellriegel, KP. (eds) Strategies in Clinical Hematology. Recent Results in Cancer Research / Fortschritte der Krebsforschung / Progrès dans les recherches sur le cancer, vol 69. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-81371-9_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-81371-9_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-81373-3

  • Online ISBN: 978-3-642-81371-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics